MAP
VRNA
Moody Aldrich Partners’s Verona Pharma VRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.66M | Sell |
49,302
-47,301
| -49% | -$4.47M | 0.9% | 48 |
|
|
2025
Q1 | $6.13M | Buy |
96,603
+1,661
| +2% | +$105K | 1.28% | 20 |
|
|
2024
Q4 | $4.41M | Sell |
94,942
-157,810
| -62% | -$7.33M | 0.82% | 53 |
|
|
2024
Q3 | $7.27M | Sell |
252,752
-43,193
| -15% | -$1.24M | 1.32% | 20 |
|
|
2024
Q2 | $4.28M | Sell |
295,945
-18,967
| -6% | -$274K | 0.83% | 56 |
|
|
2024
Q1 | $5.07M | Sell |
314,912
-6,249
| -2% | -$101K | 0.86% | 45 |
|
|
2023
Q4 | $6.38M | Sell |
321,161
-33,676
| -9% | -$669K | 1.15% | 26 |
|
|
2023
Q3 | $5.78M | Buy |
354,837
+13,136
| +4% | +$214K | 1.1% | 34 |
|
|
2023
Q2 | $7.22M | Sell |
341,701
-9,969
| -3% | -$211K | 1.4% | 19 |
|
|
2023
Q1 | $7.06M | Buy |
351,670
+130,487
| +59% | +$2.62M | 1.43% | 16 |
|
|
2022
Q4 | $5.78M | Sell |
221,183
-6,806
| -3% | -$178K | 1.17% | 27 |
|
|
2022
Q3 | $2.33M | Buy |
+227,989
| New | +$2.33M | 0.48% | 69 |
|